EGFR and neoplasm: The majority of previous liquid biopsy studies in patients with EGFR mutations have primarily reported the feasibility of detecting resistance and sensitizing EGFR mutations and how much earlier tumor progression can be predicted using liquid biopsy than CT-scans [12–16].